MedTrace Logo

Genetics of Appendix Cancer Study

NCT05734430 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2025-04-18

No results posted yet for this study

Summary

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Conditions

  • Appendix Cancer
  • Appendiceal Cancer
  • Appendiceal Neoplasms
  • Appendiceal Mucinous Neoplasm
  • Appendiceal Adenocarcinoma
  • Appendiceal Carcinoid Tumor
  • Appendiceal Neoplasm Malignant Secondary
  • Appendix Adenocarcinoma
  • Appendix Mucinous Neoplasm
  • Appendix Tumor
  • Appendix Cancer Metastatic
  • Appendix NET
  • Low-Grade Appendix Mucinous Neoplasm
  • High Grade Appendix Mucinous Neoplasm
  • High Grade Appendix Mucinous Adenocarcinoma

Interventions

GENETIC

Genetic profiling

Whole exome sequencing

OTHER

Retrospective tissue procurement

Collection of archived fixed-formalin, paraffin-embedded (FFPE) primary appendix tumor tissues that were previously removed

Sponsors & Collaborators

  • Andreana Holowatyj, PhD, MSCI

    lead OTHER

Principal Investigators

  • Andreana N Holowatyj, PhD, MSCI · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-11
Primary Completion
2032-11-30
Completion
2034-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734430 on ClinicalTrials.gov